4//SEC Filing
Deck Kelly 4
Accession 0001739614-24-000019
CIK 0001739614other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:54 PM ET
Size
9.5 KB
Accession
0001739614-24-000019
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-03-21$35.09/sh−3,113$109,230→ 18,130 totalExercise: $10.52Exp: 2028-11-26→ Common Stock (3,113 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-03-22$35.00/sh−110$3,850→ 18,020 totalExercise: $10.52Exp: 2028-11-26→ Common Stock (110 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-03-20$35.02/sh−16,777$587,552→ 21,243 totalExercise: $10.52Exp: 2028-11-26→ Common Stock (16,777 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
Documents
Issuer
Inhibrx, Inc.
CIK 0001739614
Entity typeother
Related Parties
1- filerCIK 0001819427
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:54 PM ET
- Size
- 9.5 KB